Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
/ Aug 01, 2023
Panel Discussion on Sustainability: Green chemistry - driving the change for the greater good!
Read more
Scientific Article
/ Sep 18, 2023
Amorphous Nasal Powder Advanced Performance: "In Vitro/Ex Vivo" Studies and Correlation with "In Vivo" Pharmacokinetics
Read more
Scientific Article
Scientific Article